BRUSSELS (Reuters) - The European Commission said on Saturday that it "strongly" regrets an announced increase in U.S.

(Reuters) -Gilead Sciences' Trodelvy in combination with Merck's blockbuster immunotherapy Keytruda lowered the risk of an ...